Themis Medicare Complete Financial Statements
THEMISMED • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Themis Medicare (THEMISMED).
Downloads include all available records across all periods.
For market performance, see the
THEMISMED stock price today
.
Profitability Ratios
Net Profit Margin
-4.82%
2025 data
EBITDA Margin
2.41%
2025 data
Operating Margin
-4.00%
2025 data
Return on Assets
-0.68%
2025 data
Return on Equity
-0.99%
2025 data
Balance Sheet Ratios
Current Ratio
10.48
2025 data
Debt to Equity
1.46
2025 data
Equity Ratio
68.54%
2025 data
Asset Turnover
0.14
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-32.5%
Year-over-Year
Net Profit Growth
-128.6%
Year-over-Year
EBITDA Growth
-91.3%
Year-over-Year
Expense Growth
-19.0%
Year-over-Year
Assets Growth
+3.9%
Year-over-Year
Equity Growth
+6.6%
Year-over-Year
Liabilities Growth
+3.9%
Year-over-Year
Operating Cash Flow Growth
+59.1%
Year-over-Year
Investing Cash Flow Growth
+25.0%
Year-over-Year
Financing Cash Flow Growth
-188.9%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 83 | 73 | 99 | 123 | 103 | 130 | 95 | 111 | 85 | 103 | 89 | 97 | 84 | 101 | 96 | 112 | 64 | 117 | 99 | 60 | 49 | 51 | 69 | 51 | 37 | 54 | 60 | 52 | 53 | 52 | 51 | 65 | 49 | 46 | 52 | 57 | 54 | 68 | 56 | 63 | 50 | 60 | 56 |
| Expenses | 81 | 79 | 108 | 100 | 89 | 94 | 88 | 92 | 70 | 75 | 74 | 70 | 65 | 74 | 74 | 84 | 50 | 72 | 78 | 45 | 33 | 36 | 50 | 45 | 43 | 44 | 45 | 47 | 43 | 46 | 47 | 53 | 41 | 45 | 45 | 53 | 45 | 57 | 43 | 52 | 42 | 50 | 46 |
| EBITDA | 2 | -6 | -9 | 23 | 14 | 36 | 7 | 19 | 16 | 28 | 14 | 28 | 19 | 27 | 22 | 28 | 15 | 45 | 22 | 14 | 16 | 15 | 19 | 7 | -5 | 10 | 15 | 4 | 11 | 5 | 4 | 12 | 9 | 2 | 7 | 4 | 10 | 11 | 13 | 11 | 9 | 10 | 10 |
| Operating Profit Margin % | -4.00% | -11.00% | -10.00% | 15.00% | 10.00% | 24.00% | 6.00% | 12.00% | 13.00% | 22.00% | 10.00% | 23.00% | 18.00% | 22.00% | 17.00% | 22.00% | 20.00% | 36.00% | 18.00% | 18.00% | 29.00% | 25.00% | 23.00% | 11.00% | -19.00% | 15.00% | 17.00% | 4.00% | 19.00% | 8.00% | 3.00% | 15.00% | 17.00% | 1.00% | 10.00% | 6.00% | 17.00% | 14.00% | 20.00% | 18.00% | 16.00% | 14.00% | 16.00% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 4 | 3 | 3 |
| Interest | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | -4 | -11 | -14 | 18 | 9 | 31 | 2 | 14 | 10 | 23 | 8 | 23 | 14 | 22 | 18 | 23 | 9 | 40 | 17 | 9 | 10 | 10 | 14 | 1 | -10 | 5 | 10 | -1 | 6 | 1 | -1 | 7 | 4 | -3 | 2 | -1 | 3 | 7 | 8 | 7 | 2 | 6 | 4 |
| Tax | 0 | -2 | 0 | 4 | 2 | 7 | 1 | 3 | 2 | 4 | 1 | 5 | 4 | 5 | 4 | 4 | 1 | 9 | 5 | 0 | 3 | 2 | 2 | -1 | 0 | 0 | 0 | 0 | 1 | 0 | -1 | 0 | 3 | 0 | 0 | -3 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| Net Profit | -4 | -10 | -14 | 14 | 7 | 25 | 1 | 11 | 8 | 18 | 7 | 18 | 10 | 17 | 13 | 19 | 8 | 31 | 13 | 8 | 7 | 8 | 12 | 2 | -10 | 5 | 11 | 0 | 5 | 1 | 0 | 7 | 0 | -3 | 3 | 2 | 3 | 7 | 6 | 7 | 2 | 6 | 5 |
| Earnings Per Share (₹) | -0.39 | -1.05 | -1.54 | 1.55 | 0.72 | 2.68 | 0.06 | 12.30 | 9.13 | 19.77 | 0.80 | 19.33 | 10.81 | 18.92 | 14.47 | 20.95 | 8.76 | 33.93 | 13.54 | 8.85 | 7.92 | 8.44 | 12.80 | 1.83 | -10.79 | 5.62 | 11.62 | -0.32 | 5.10 | 0.92 | 0.12 | 7.76 | 0.48 | -3.32 | 2.77 | 2.37 | 3.77 | 8.14 | 7.05 | 7.77 | 2.65 | 6.90 | 5.61 |
Related Pages for Themis Medicare
Additional stock information and data for THEMISMED
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 588 | 566 | 514 | 428 | 371 | 350 | 314 | 305 | 289 | 275 | 277 |
| Current Assets | 304 | 293 | 265 | 214 | 186 | 181 | 150 | 143 | 124 | 133 | 134 |
| Fixed Assets | 172 | 168 | 162 | 144 | 133 | 116 | 123 | 126 | 124 | 117 | 122 |
| Capital Work in Progress | 3 | 3 | 3 | 3 | 3 | 8 | 3 | 3 | 9 | 6 | 4 |
| Investments | 95 | 89 | 70 | 56 | 45 | 36 | 27 | 24 | 23 | 0 | 0 |
| Other Assets | 318 | 307 | 279 | 225 | 191 | 191 | 162 | 153 | 134 | 151 | 151 |
| LIABILITIES | |||||||||||
| Total Liabilities | 588 | 566 | 514 | 428 | 371 | 350 | 314 | 305 | 289 | 275 | 277 |
| Current Liabilities | 29 | 36 | 35 | 31 | 24 | 12 | 9 | 12 | 12 | 71 | 82 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 403 | 378 | 339 | 288 | 219 | 183 | 158 | 169 | 152 | 74 | 59 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 393 | 369 | 330 | 278 | 209 | 174 | 149 | 160 | 143 | 66 | 51 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 35 | 22 | 16 | 34 | 57 | 0 | 11 | 8 | -2 | 26 | 19 |
| Investing Activities | -12 | -16 | -24 | -16 | -16 | -6 | -4 | 0 | -4 | -7 | -6 |
| Financing Activities | -26 | -9 | 0 | -18 | -26 | 7 | -10 | -9 | 5 | -13 | -18 |
| Net Cash Flow | -3 | -3 | -8 | 1 | 16 | 2 | -3 | -1 | 0 | 5 | -5 |